BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6277477)

  • 1. Mammary tumor virus DNA as a marker for genotypic variance within hormone-responsive GR mouse mammary tumors.
    Michalides R; Wagenaar E; Sluyser M
    Cancer Res; 1982 Mar; 42(3):1154-8. PubMed ID: 6277477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of biologic behavior and histology of transplanted mammary tumors in GR mice.
    Percy DH; Morris VL; MacInnes JI
    J Natl Cancer Inst; 1982 Oct; 69(4):933-8. PubMed ID: 6288995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of acquired mouse mammary tumor virus DNA during mammary tumorigenesis in BALB/cfC3H mice.
    Cardiff RD; Morris DW; Young LJ
    J Natl Cancer Inst; 1983 Nov; 71(5):1011-9. PubMed ID: 6316008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of mammary tumor virus in hormone-dependent and -independent mouse mammary tumor cells.
    Sluyser M; Nouwen T; Hilgers J; Calafat J
    Cancer Res; 1977 Jul; 37(7 Pt 1):1986-90. PubMed ID: 193632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
    Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment with cyclophosphamide on hormone-dependent and hormone-independent tumor cells in transplanted GR mouse mammary tumors.
    Sluyser M; Benckhuysen C
    Cancer Treat Rep; 1977 Aug; 61(5):861-7. PubMed ID: 890694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of milk-transmitted murine mammary tumor virus (MMTV) among mouse strains.
    Sayama K; Takeda Y; Hashimoto H; Kaneko T; Matsuzawa A
    In Vivo; 1999; 13(2):135-40. PubMed ID: 10363169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors.
    Roelink H; Wagenaar E; Nusse R
    Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
    Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary tumor virus proviral DNA in normal murine tissue and non-virally induced mammary tumors.
    Michalides R; Wagenaar E; Groner B; Hynes NE
    J Virol; 1981 Aug; 39(2):367-76. PubMed ID: 6268828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P; Briand P; Hartmann NR
    Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variance among cells isolated from spontaneous mouse mammary tumors in primary suspension culture.
    Soule HD; Maloney T; McGrath CM
    Cancer Res; 1981 Mar; 41(3):1154-64. PubMed ID: 7459857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse mammary tumor virus derived from wild mice does not target Notch-4 protooncogene for the development of mammary tumors in inbred mice.
    Sarkar NH
    Virology; 2009 May; 388(1):121-7. PubMed ID: 19329137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
    Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
    Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic evidence of a loss of iodination within hormone-dependent GR mouse mammary tumors as they progress to independence.
    Strum JM
    Anat Rec; 1982 Dec; 204(4):323-32. PubMed ID: 7181137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.